Cleared Traditional

K812821 - H-103 IGG

K812821 is the FDA 510(k) clearance for H-103 IGG by Immulok, Inc.. It is a Class 2 Immunology device (product code DFZ) cleared through the Traditional 510(k) pathway after a 19-day FDA review.

K812821 · Immulok, Inc. · Immunology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Oct 1981
Decision
19d
Days
Class 2
Risk

K812821 is an FDA 510(k) clearance for the H-103 IGG, H-104 IGA, H-105 IGM. Classified as Igg (gamma Chain Specific), Antigen, Antiserum, Control (product code DFZ), Class II - Special Controls.

Submitted by Immulok, Inc. (Mchenry, US). The FDA issued a Cleared decision on October 26, 1981 after a review of 19 days - a notably fast clearance cycle.

This device falls under the Immunology FDA review panel, regulated under 21 CFR 866.5510 - the FDA immunology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Immulok, Inc. devices

Submission Details

510(k) Number K812821 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 07, 1981
Decision Date October 26, 1981
Days to Decision 19 days
Submission Type Traditional
Review Panel Immunology (IM)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
85d faster than avg
Panel avg: 104d · This submission: 19d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code DFZ Igg (gamma Chain Specific), Antigen, Antiserum, Control
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 866.5510
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Immunology devices follow this clearance model.

Regulatory Peers - DFZ Igg (gamma Chain Specific), Antigen, Antiserum, Control

All 7
Devices cleared under the same product code (DFZ) and FDA review panel - the closest regulatory comparables to K812821.
HUMAN IGG SUBCLASS LIQUID REAGENT KITS FOR USE ON THE HITACHI 911/7070 TURBIDIMETRIC ANALYSER
K021081 · The Binding Site, Ltd. · Jun 2002
BOEHRINGER MANNHEIM IGG ASSAY
K955906 · Boehringer Mannheim Corp. · Feb 1996
IGG SUBCLASS SINGLE DILUTION DIAGNOSTIC KIT FOR USE WITH THE BECKMAN ARRAY ANALYZER
K940422 · The Binding Site, Ltd. · May 1994
AUTOMATED IMMUNOPRECIPITIN METHOD/ICG
K803272 · Icl Scientific · Jan 1981
ANTISERUM TO RABBIT IMMUNOGLOBULIN
K790709 · Kent Laboratories, Inc. · Aug 1979
ANTISERA TO RABBIT IMMUNOGLOBULIN
K790720 · Kent Laboratories, Inc. · Aug 1979